Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15951)

• Formulation Name: Ondansetron 24 mg tablet
• Company: Taro Pharmaceuticals USA

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	(DMOTQ1I)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Eisenoxyd	(E00585)	56841934	Colorant
FD&C blue no. 2	(E00446)	2723854	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent